Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Database
Language
Publication year range
1.
J Neurochem ; 114(6): 1687-700, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20584104

ABSTRACT

Peripheral inflammation could play a role in the origin and development of certain neurodegenerative disorders. To ascertain this possibility, a model of dopaminergic neurodegeneration based on the injection of the inflammatory agent lipopolysaccharide (LPS) within the substantia nigra was assayed in rats with ulcerative colitis (UC) induced by the ingestion of dextran sulphate sodium. We found an increase in the levels of inflammatory markers from serum (tumor necrosis factor-α, IL-1ß, IL-6 and the acute phase protein C-reactive protein) and substantia nigra (tumor necrosis factor-α, IL-1ß, IL-6, inducible nitric oxide synthase, intercellular adhesion molecule-1, microglial and astroglial populations) of rats with UC, as well as an alteration of the blood-brain barrier permeability and the loss of dopaminergic neurons. UC reinforced the inflammatory and deleterious effects of LPS. On the contrary, clodronate encapsulated in liposomes (ClodLip), which depletes peripheral macrophages, ameliorated the effect of LPS and UC. Peripheral inflammation might represent a risk factor in the development of Parkinson's disease.


Subject(s)
Colitis, Ulcerative/pathology , Dopamine/physiology , Lipopolysaccharides/pharmacology , Parkinson Disease/etiology , Substantia Nigra/pathology , Animals , Astrocytes/metabolism , Astrocytes/pathology , Blood-Brain Barrier/metabolism , C-Reactive Protein/metabolism , Colitis, Ulcerative/complications , Colitis, Ulcerative/metabolism , Cytokines/metabolism , Dextran Sulfate , Intercellular Adhesion Molecule-1/metabolism , Macrophages/pathology , Male , Microglia/metabolism , Neurons/drug effects , Neurons/pathology , Nitric Oxide Synthase Type II/metabolism , Parkinson Disease/metabolism , Parkinson Disease/pathology , Rats , Rats, Wistar , Risk Factors , Serum , Substantia Nigra/drug effects , Substantia Nigra/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL